buyWeak
Shah Capital Management bought $104k of SOL
CHAIRMAN at Emeren Group Ltd. 58,921 shares at an average of $1.77, traded Dec 12, 2024, filed Dec 16, 2024.
Conviction score
25Value
$104k
58,921 shares
Holdings after
18,801,383
+0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleChair
- +10Trade size$104k at market
- -5Relative to holdingsUnder 1% of holdings (0.3%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001383838-24-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2024 | POpen-market purchase American Depositary Sharesindirect: Refer to Footnote 3 | +12,710 | $1.77 | $22k | 18,755,172 | Dec 16, 2024 |
| Dec 13, 2024 | POpen-market purchase American Depositary Sharesindirect: Refer to Footnote 3 | +46,211 | $1.77 | $82k | 18,801,383 | Dec 16, 2024 |
Related signals
Other insiders at Emeren Group Ltd and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $30k 16,853 shares | +0% | |
| 45Moderate | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $1.4M 596,118 shares | +3% | |
| 31Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $379k 155,070 shares | +1% | |
| 37Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $435k 187,096 shares | +1% | |
| 35Weak | SOLbuy Emeren Group Ltd | Shah Capital Management CHAIRMAN | $617k 268,014 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.